Mortality Rate

Mortality rate in insurance is the measure of the number of deaths in a specific population over a particular period. It is a critical factor in determining the risk associated with a life insurance policy and is used to calculate the premiums charged by insurers. Mortality rates can be calculated based on various factors, including age, gender, and health conditions.

Here are some key features of mortality rate in insurance:

• Mortality rate is expressed as the number of deaths per unit of population per unit of time, typically expressed as deaths per 1,000 or 100,000 people per year.

• Mortality rates can be calculated for different age groups and genders, as mortality rates can vary significantly depending on these factors.

• Mortality tables, also known as life tables, are used by insurance companies to calculate premiums based on the probability of death for individuals based on their age, gender, and health status.

• Mortality rates are used to determine the expected loss ratio for a life insurance policy, which is the ratio of claims paid out to the total premiums collected over a specific period.

• Mortality rates can also be used to compare the risk of death between different populations, such as comparing mortality rates between countries or regions.

For example, an insurance company may use mortality rates to calculate the premiums for a life insurance policy. The premiums charged will depend on the age, gender, and health status of the policyholder, as well as other factors such as lifestyle habits and family medical history. By using mortality tables, the insurer can estimate the probability of the policyholder's death and charge an appropriate premium to cover the risk.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.